421 related articles for article (PubMed ID: 30420667)
21. Getting personal with myelodysplastic syndromes: is now the right time?
Chokr N; Pine AB; Bewersdorf JP; Shallis RM; Stahl M; Zeidan AM
Expert Rev Hematol; 2019 Apr; 12(4):215-224. PubMed ID: 30977414
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
Sahajpal NS; Mondal AK; Ananth S; Njau A; Ahluwalia P; Jones K; Ahluwalia M; Okechukwu N; Savage NM; Kota V; Rojiani AM; Kolhe R
PLoS One; 2020; 15(10):e0240976. PubMed ID: 33075099
[TBL] [Abstract][Full Text] [Related]
23. Detection of the KIT
Craig JW; Hasserjian RP; Kim AS; Aster JC; Pinkus GS; Hornick JL; Steensma DP; Coleman Lindsley R; DeAngelo DJ; Morgan EA
Mod Pathol; 2020 Jun; 33(6):1135-1145. PubMed ID: 31896808
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
25. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
26. Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.
Cheng DT; Cheng J; Mitchell TN; Syed A; Zehir A; Mensah NYT; Oultache A; Nafa K; Levine RL; Arcila ME; Berger MF; Hedvat CV
J Mol Diagn; 2014 Sep; 16(5):504-518. PubMed ID: 25017477
[TBL] [Abstract][Full Text] [Related]
27. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
[TBL] [Abstract][Full Text] [Related]
28. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.
Patel B; Hirsch C; Clemente M; Sekeres M; Makishima H; Maciejewski JP
Int J Hematol; 2015 Mar; 101(3):213-8. PubMed ID: 25690487
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic biomarkers in myeloid malignancies.
Matynia AP; Szankasi P; Shen W; Kelley TW
Arch Pathol Lab Med; 2015 May; 139(5):594-601. PubMed ID: 25152312
[TBL] [Abstract][Full Text] [Related]
30. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
31. Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Palomo L; Ibáñez M; Abáigar M; Vázquez I; Álvarez S; Cabezón M; Tazón-Vega B; Rapado I; Fuster-Tormo F; Cervera J; Benito R; Larrayoz MJ; Cigudosa JC; Zamora L; Valcárcel D; Cedena MT; Acha P; Hernández-Sánchez JM; Fernández-Mercado M; Sanz G; Hernández-Rivas JM; Calasanz MJ; Solé F; Such E;
Br J Haematol; 2020 Mar; 188(5):605-622. PubMed ID: 31621063
[TBL] [Abstract][Full Text] [Related]
32. The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML).
Yun S; Geyer SM; Komrokji RS; Al Ali NH; Song J; Hussaini M; Sweet KL; Lancet JE; List AF; Padron E; Sallman DA
Leukemia; 2021 Apr; 35(4):1145-1155. PubMed ID: 32728186
[TBL] [Abstract][Full Text] [Related]
34. A geno-clinical decision model for the diagnosis of myelodysplastic syndromes.
Radakovich N; Meggendorfer M; Malcovati L; Hilton CB; Sekeres MA; Shreve J; Rouphail Y; Walter W; Hutter S; Galli A; Pozzi S; Elena C; Padron E; Savona MR; Gerds AT; Mukherjee S; Nagata Y; Komrokji RS; Jha BK; Haferlach C; Maciejewski JP; Haferlach T; Nazha A
Blood Adv; 2021 Nov; 5(21):4361-4369. PubMed ID: 34592765
[TBL] [Abstract][Full Text] [Related]
35. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China.
Li J; Pei L; Liang S; Xu S; Wang Y; Wang X; Liao Y; Zhan Q; Cheng W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang L
Cancer Med; 2023 Apr; 12(8):9332-9350. PubMed ID: 36799265
[TBL] [Abstract][Full Text] [Related]
36. The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies.
Öz Puyan F; Alkan S
Balkan Med J; 2019 Feb; 36(2):78-87. PubMed ID: 30251956
[TBL] [Abstract][Full Text] [Related]
37. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
[TBL] [Abstract][Full Text] [Related]
38. Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies.
Hogg G; Severson EA; Cai L; Hoffmann HM; Holden KA; Fitzgerald K; Kenyon A; Zeng Q; Mooney M; Gardner S; Chen W; Nagan N; Boles D; Parker S; Richman TJ; Letovsky S; Dong H; Anderson SM; Ramkissoon S; Reddy P; Eisenberg M; Chenn A; Jensen TJ
Cancer Genet; 2023 Nov; 278-279():38-49. PubMed ID: 37586297
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
[No Abstract] [Full Text] [Related]
40. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
